Try our Advanced Search for more refined results

Expert Analysis

Drug Design Defect Litigation Faces Its Demise

By James Beck (December 5, 2018, 2:01 PM EST) -- "The Demise of Drug Design Litigation: Death by Federal Preemption" is the intriguing title of the latest law review article written by the "Rabbi of Torts," Prof. Aaron Twerski (we're not making this up — Twerski's Wikipedia page is the fifth result when we just Googled that phrase). Twerski, one of the American Law Institute's reporters for the Restatement (Third) of Torts: Products Liability, has probably spilled as much ink as anyone in making sense of Restatement (Second) of Torts Section 402A, comment k (1965), one of the more opaque parts of the venerable Section 402A....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!